Industry News

Oct 04, 2017
By BioPharm International Editors
The Danish biotechnology company has been awarded a sole-source BARDA contract valued at more than $539 million for a freeze-dried smallpox vaccine.
Oct 04, 2017
By BioPharm International Editors
Aptar Pharma will be a main exhibitor at CPhI Worldwide 2017 and will deliver three briefings on company drug-delivery developments.
Oct 03, 2017
By BioPharm International Editors
The Cell and Gene Therapy Catapult, one of UK’s centers of excellence, has partnered with Japan’s Forum for Innovative Regenerative Medicine to boost their respective stances in the global cell and gene therapy landscape.
Sep 29, 2017
By BioPharm International Editors
The US Department of Justice reports that AmerisourceBergen has pled guilty to illegally distributing misbranded oncology drugs and will pay a $260-million penalty.
Sep 28, 2017
By BioPharm International Editors
The International Society for Pharmaceutical Engineering (ISPE) has revealed the results of its 2017–2018 International Board of Directors election.
Sep 28, 2017
By BioPharm International Editors
The agency will require training for healthcare providers who prescribe immediate-release opioids.
Sep 28, 2017
By BioPharm International Editors
The draft guidance gives recommendations for reproductive toxicity testing and labeling.
Sep 28, 2017
By BioPharm International Editors
FDA sent a warning letter to Shandong Vianor Biotech Co., Ltd. that claimed the company failed to follow proper data integrity and quality control procedures.
Sep 26, 2017
By BioPharm International Editors
Staff survey on the relocation of EMA indicates that the future of public health in Europe is at stake.
Sep 25, 2017
By BioPharm International Editors
FDA participated in a global operation to combat the sale and distribution of unapproved and illegal drugs.
native1_300x100
lorem ipsum